Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Approval is based on positive data from the Phase 3 ECHELON-3 trial
The conference featured comprehensive discussions, field visits, and knowledge-sharing sessions addressing different aspect of major NCDs
Prithwish has close to 28 years of experience in a Commercial role
Smeeta Bhatkal, Santosh Desai and Akshay Kumar join as Independent Directors; Shaina NC as Non-Executive Director
Exploring new opportunities within the fast-growing market of microfluidics
This facility marks a significant milestone in transforming the global food industr
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
Subscribe To Our Newsletter & Stay Updated
